Source: International Congress 2015 – Connective tissue disorders
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Joanna Woźniak (Bydgoszcz, Poland), Joanna Wozniak, Tomasz Wandtke, Piotr Kopinski, Joanna Chorostowska, Agata Gizycka, Cezary Rybacki, Iwona Patyk, Blazej Przybyslawski, Andrzej Redziak. Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe. Eur Respir J 2015; 46: Suppl. 59, 3806

Member's Comments

No comment yet.

Related content which might interest you: Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016